Amneal Pharmaceuticals, Inc 10-K for FY2023
Amneal Pharmaceuticals, Inc. (AMRX)
10-K
2024-03-14
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 10-K
Amneal Pharmaceuticals, Inc filed this 10-K on March 14, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.39B
- up 8.2% from $2.21B a year earlier
- Net loss
- $79.27M
- compared with a net loss of $270.58M a year earlier
- Diluted EPS
- -$0.48
- compared with -$0.86 a year earlier